Trillo Aliaga, P.; Del Signore, E.; Fuorivia, V.; Spitaleri, G.; Asnaghi, R.; Attili, I.; Corvaja, C.; Carnevale Schianca, A.; Passaro, A.; de Marinis, F.
The Evolving Scenario of ES-SCLC Management: From Biology to New Cancer Therapeutics. Genes 2024, 15, 701.
https://doi.org/10.3390/genes15060701
AMA Style
Trillo Aliaga P, Del Signore E, Fuorivia V, Spitaleri G, Asnaghi R, Attili I, Corvaja C, Carnevale Schianca A, Passaro A, de Marinis F.
The Evolving Scenario of ES-SCLC Management: From Biology to New Cancer Therapeutics. Genes. 2024; 15(6):701.
https://doi.org/10.3390/genes15060701
Chicago/Turabian Style
Trillo Aliaga, Pamela, Ester Del Signore, Valeria Fuorivia, Gianluca Spitaleri, Riccardo Asnaghi, Ilaria Attili, Carla Corvaja, Ambra Carnevale Schianca, Antonio Passaro, and Filippo de Marinis.
2024. "The Evolving Scenario of ES-SCLC Management: From Biology to New Cancer Therapeutics" Genes 15, no. 6: 701.
https://doi.org/10.3390/genes15060701
APA Style
Trillo Aliaga, P., Del Signore, E., Fuorivia, V., Spitaleri, G., Asnaghi, R., Attili, I., Corvaja, C., Carnevale Schianca, A., Passaro, A., & de Marinis, F.
(2024). The Evolving Scenario of ES-SCLC Management: From Biology to New Cancer Therapeutics. Genes, 15(6), 701.
https://doi.org/10.3390/genes15060701